SPINK1 tumor cell expression and possible prognostic value have been most studied in prostate cancer, where SPINK1 positive tumors form a subgroup of about 10–15% of prostate cancers (Tomlins et al., 2008; Ateeq et al., 2011, 2015). This evidence concerns the gene SPINK1 and neoplasm.